Free medical insurance Link generic viagra caverta 2c cialis cheap This stock has become li’l more than a tool for the insiders/institutions/funds who pretty much own the float outright to shovel shares back and forth to bump the price in order to trap and loot short sellers. the numbers don’t add up. No one is applying affordability to the equation. The CEO guesstimates 15,000 afflicted with HoFH worldwide (more’n double the FDA estimate of one in a million). Based upon 2009 IRS statistics roughly one in two hundred Americans could (if they chose) afford a 300K prescription, course weテ「ツツ决e more affluent than most in the world, USA GDP per capita is $49,800 (2012 est.), World GDP per capita is $12,400 (2012 est.), accordingly youテ「ツツ囘 have to assume a much smaller ratio able to afford it on a worldwide basis, assuming one in a thousand (probably still far too high) persons could afford the prescription (and choose it over less expensive treatments), youテ「ツツ囘 have a grand total of 15 customers and 4.5 million in annual revenue…don’t be fooled by short term results, it’s an accounting game, bottom line they’re still losing money…with a 2,500 million market cap created of BS and price fixing.
|
